PL369601A1 - Pochodne eteru alkilowego lub ich sole - Google Patents
Pochodne eteru alkilowego lub ich soleInfo
- Publication number
- PL369601A1 PL369601A1 PL02369601A PL36960102A PL369601A1 PL 369601 A1 PL369601 A1 PL 369601A1 PL 02369601 A PL02369601 A PL 02369601A PL 36960102 A PL36960102 A PL 36960102A PL 369601 A1 PL369601 A1 PL 369601A1
- Authority
- PL
- Poland
- Prior art keywords
- alkyl ether
- ether derivatives
- salts
- new
- optionally substituted
- Prior art date
Links
- 150000005215 alkyl ethers Chemical class 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 3
- HQNACSFBDBYLJP-UHFFFAOYSA-N 1-[3-[2-(1-benzothiophen-5-yl)ethoxy]propyl]azetidin-3-ol Chemical compound C1C(O)CN1CCCOCCC1=CC=C(SC=C2)C2=C1 HQNACSFBDBYLJP-UHFFFAOYSA-N 0.000 abstract 2
- 230000008929 regeneration Effects 0.000 abstract 2
- 238000011069 regeneration method Methods 0.000 abstract 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 1
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 239000000480 calcium channel blocker Substances 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- -1 hydroxy, amino Chemical group 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001321381 | 2001-10-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL369601A1 true PL369601A1 (pl) | 2005-05-02 |
| PL215264B1 PL215264B1 (pl) | 2013-11-29 |
Family
ID=19138603
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL402986A PL217872B1 (pl) | 2001-10-19 | 2002-10-18 | Pochodna eteru alkilowego lub jej sól, stanowiąca 1-{3-[2-(1-benzotiofen-5-ylo)etoksy]propylo}-3-azetydynol lub jego sól |
| PL369601A PL215264B1 (pl) | 2001-10-19 | 2002-10-18 | Pochodne eteru alkilowego lub ich sole, sposób ich wytwarzania oraz kompozycja farmaceutyczna |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL402986A PL217872B1 (pl) | 2001-10-19 | 2002-10-18 | Pochodna eteru alkilowego lub jej sól, stanowiąca 1-{3-[2-(1-benzotiofen-5-ylo)etoksy]propylo}-3-azetydynol lub jego sól |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US7087594B2 (pl) |
| EP (1) | EP1437353B1 (pl) |
| JP (1) | JP4398247B2 (pl) |
| KR (1) | KR100956990B1 (pl) |
| CN (2) | CN100500662C (pl) |
| AT (1) | ATE364604T1 (pl) |
| AU (1) | AU2002344107B2 (pl) |
| BR (1) | BRPI0213393B8 (pl) |
| CA (1) | CA2464358C (pl) |
| CY (1) | CY1106714T1 (pl) |
| DE (1) | DE60220694T2 (pl) |
| DK (1) | DK1437353T3 (pl) |
| ES (1) | ES2287324T3 (pl) |
| HU (1) | HU230407B1 (pl) |
| IL (2) | IL161308A0 (pl) |
| MX (1) | MXPA04003541A (pl) |
| NO (1) | NO325780B1 (pl) |
| NZ (1) | NZ532328A (pl) |
| PL (2) | PL217872B1 (pl) |
| PT (1) | PT1437353E (pl) |
| RO (1) | RO122203B1 (pl) |
| WO (1) | WO2003035647A1 (pl) |
| ZA (1) | ZA200402806B (pl) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2464358C (en) | 2001-10-19 | 2011-05-24 | Toyama Chemical Co., Ltd. | Alkyl ether derivatives or their salts |
| NZ537090A (en) | 2002-06-14 | 2006-02-24 | Toyama Chemical Co Ltd | Medicinal compositions improving brain function and method for improving brain function |
| CA2521648C (en) * | 2003-04-17 | 2012-07-03 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| BRPI0609496C8 (pt) * | 2005-03-28 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivado do éster do ácido propiônico |
| RU2397169C2 (ru) * | 2005-03-28 | 2010-08-20 | Тояма Кемикал Ко., Лтд. | Способ получения 1-(3-(2-(1-бензотиофен-5-ил)этокси) пропил)азетидин-3-ола или его солей |
| AU2011204959B2 (en) * | 2005-03-28 | 2012-04-12 | Toyama Chemical Co., Ltd. | Process for production of 1-(3-(2-(1-benzothiophen-5-YL)- ethoxy)propyl)azetidin-3-ol or salts thereof |
| JP4902247B2 (ja) * | 2005-04-08 | 2012-03-21 | 富山化学工業株式会社 | ２−（１−ベンゾチオフェン−５−イル）エタノールの新規製造法およびその中間体 |
| JP2006328058A (ja) * | 2005-04-27 | 2006-12-07 | Toyama Chem Co Ltd | ２−（１−ベンゾチオフェン−５−イル）エタノールの新規製造法およびその中間体 |
| US8119625B2 (en) * | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| AU2007244409B2 (en) * | 2006-04-26 | 2011-12-01 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| ZA200900743B (en) * | 2006-08-04 | 2010-05-26 | Toyama Chemical Co Ltd | Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof |
| JP5552424B2 (ja) * | 2008-05-28 | 2014-07-16 | 富山化学工業株式会社 | 新規なベンゾチオフェンオキシド誘導体またはその塩 |
| ES2721666T3 (es) | 2012-02-22 | 2019-08-02 | Fujifilm Toyama Chemical Co Ltd | Composición farmacéutica sólida que contiene 1-(3-(2-(1-benzotiofen-5-il)etoxi)propil)azetidin-3-ol o una sal del mismo |
| AU2015211753B2 (en) | 2014-01-31 | 2019-09-12 | Fujifilm Toyama Chemical Co., Ltd. | Post nerve injury rehabilitation effect-enhancing agent comprising alkyl ether derivative or salt thereof |
| EP3308782B1 (en) * | 2015-06-11 | 2022-01-19 | Toyama Chemical Co., Ltd. | Sigma-receptor binding agent |
| JP6860502B2 (ja) | 2015-12-25 | 2021-04-14 | 富士フイルム富山化学株式会社 | １−（３−（２−（１−ベンゾチオフェン−５−イル）エトキシ）プロピル）アゼチジン−３−オールまたはその塩を含む錠剤 |
| WO2018124284A1 (ja) | 2016-12-28 | 2018-07-05 | 富山化学工業株式会社 | 医薬組成物 |
| WO2018124281A1 (ja) | 2016-12-28 | 2018-07-05 | 富山化学工業株式会社 | 外用組成物 |
| US11234962B2 (en) | 2016-12-28 | 2022-02-01 | Fujifilm Toyama Chemical Co., Ltd. | Pharmaceutical composition and method of manufacturing the same |
| CN110167551B (zh) | 2016-12-28 | 2022-06-14 | 富士胶片富山化学株式会社 | 医药组合物 |
| CN110691595A (zh) | 2017-06-02 | 2020-01-14 | 富士胶片富山化学株式会社 | β-淀粉样蛋白量减少剂 |
| JP7370859B2 (ja) | 2017-06-02 | 2023-10-30 | 富士フイルム富山化学株式会社 | タウオパチー予防または治療剤 |
| CN110709078A (zh) | 2017-06-02 | 2020-01-17 | 富士胶片富山化学株式会社 | 脑萎缩预防或治疗剂 |
| RU2728717C1 (ru) * | 2017-06-02 | 2020-07-30 | ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. | Средство для профилактики или лечения спиноцеребеллярной атаксии |
| JPWO2018221728A1 (ja) | 2017-06-02 | 2020-04-02 | 富士フイルム富山化学株式会社 | アルツハイマー型認知症予防または治療剤 |
| WO2019088083A1 (ja) | 2017-10-30 | 2019-05-09 | 富士フイルム富山化学株式会社 | エモパミル結合タンパク質結合剤およびその利用 |
| CN114853619B (zh) * | 2022-05-19 | 2024-05-10 | 神隆医药（常熟）有限公司 | 一种适于工业化生产的n-甲基酪胺盐酸盐的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01156973A (ja) | 1987-09-04 | 1989-06-20 | Tanabe Seiyaku Co Ltd | ベンゾフラン誘導体 |
| JP2887492B2 (ja) | 1990-02-05 | 1999-04-26 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| JP3044055B2 (ja) | 1990-08-09 | 2000-05-22 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| DK74693D0 (da) | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| JP3232830B2 (ja) | 1993-11-30 | 2001-11-26 | 三菱電機株式会社 | フレキシブルディスク装置のキャリッジ機構 |
| EP1020427B1 (en) * | 1994-10-25 | 2003-10-01 | Toyama Chemical Co., Ltd. | Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| JPH08268883A (ja) | 1994-10-25 | 1996-10-15 | Toyama Chem Co Ltd | １−フェニル−１，２−エタンジオール誘導体またはそ の塩を含有する神経成長因子の作用増強剤 |
| CN1198739A (zh) | 1995-08-11 | 1998-11-11 | 美国辉瑞有限公司 | (1s,2s)－1－(4－羟基苯基)－2－(4－羟基－4－苯基哌啶－1－基)－1－丙醇甲磺酸盐三水合物 |
| EP0873990A1 (en) | 1995-09-22 | 1998-10-28 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and medicinal use thereof |
| DE19605610A1 (de) | 1996-02-15 | 1997-08-21 | Hoechst Ag | Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| WO1997030703A1 (en) | 1996-02-20 | 1997-08-28 | Toyama Chemical Co., Ltd. | Cerebral function ameliorant containing 1,2-ethanediol derivatives or salts thereof |
| AU1506499A (en) * | 1997-12-12 | 1999-07-05 | Toyama Chemical Co. Ltd. | Alkyl ether derivatives or salts thereof and calcium antagonists containing the same |
| JP4549452B2 (ja) | 1997-12-12 | 2010-09-22 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤 |
| NZ515706A (en) | 1999-06-11 | 2003-08-29 | Toyama Chemical Co Ltd | N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| CA2464358C (en) | 2001-10-19 | 2011-05-24 | Toyama Chemical Co., Ltd. | Alkyl ether derivatives or their salts |
| NZ537090A (en) | 2002-06-14 | 2006-02-24 | Toyama Chemical Co Ltd | Medicinal compositions improving brain function and method for improving brain function |
| CA2521648C (en) | 2003-04-17 | 2012-07-03 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| BRPI0609496C8 (pt) | 2005-03-28 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivado do éster do ácido propiônico |
| AU2007244409B2 (en) | 2006-04-26 | 2011-12-01 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| US8119625B2 (en) | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| ZA200900743B (en) | 2006-08-04 | 2010-05-26 | Toyama Chemical Co Ltd | Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof |
| JP5552424B2 (ja) | 2008-05-28 | 2014-07-16 | 富山化学工業株式会社 | 新規なベンゾチオフェンオキシド誘導体またはその塩 |
-
2002
- 2002-10-18 CA CA2464358A patent/CA2464358C/en not_active Expired - Lifetime
- 2002-10-18 CN CNB028206452A patent/CN100500662C/zh not_active Expired - Lifetime
- 2002-10-18 AT AT02777882T patent/ATE364604T1/de active
- 2002-10-18 US US10/492,774 patent/US7087594B2/en not_active Ceased
- 2002-10-18 IL IL16130802A patent/IL161308A0/xx unknown
- 2002-10-18 NZ NZ532328A patent/NZ532328A/en not_active IP Right Cessation
- 2002-10-18 KR KR1020047005687A patent/KR100956990B1/ko not_active Expired - Lifetime
- 2002-10-18 AU AU2002344107A patent/AU2002344107B2/en not_active Expired
- 2002-10-18 BR BRPI0213393A patent/BRPI0213393B8/pt not_active IP Right Cessation
- 2002-10-18 PL PL402986A patent/PL217872B1/pl unknown
- 2002-10-18 US US13/327,152 patent/USRE43676E1/en not_active Expired - Lifetime
- 2002-10-18 HU HU0500017A patent/HU230407B1/hu unknown
- 2002-10-18 MX MXPA04003541A patent/MXPA04003541A/es active IP Right Grant
- 2002-10-18 PT PT02777882T patent/PT1437353E/pt unknown
- 2002-10-18 CN CN2009102038534A patent/CN101643470B/zh not_active Expired - Lifetime
- 2002-10-18 EP EP02777882A patent/EP1437353B1/en not_active Expired - Lifetime
- 2002-10-18 WO PCT/JP2002/010827 patent/WO2003035647A1/ja not_active Ceased
- 2002-10-18 ES ES02777882T patent/ES2287324T3/es not_active Expired - Lifetime
- 2002-10-18 DK DK02777882T patent/DK1437353T3/da active
- 2002-10-18 RO ROA200400354A patent/RO122203B1/ro unknown
- 2002-10-18 PL PL369601A patent/PL215264B1/pl unknown
- 2002-10-18 DE DE60220694T patent/DE60220694T2/de not_active Expired - Lifetime
- 2002-10-18 JP JP2003538163A patent/JP4398247B2/ja not_active Expired - Lifetime
-
2004
- 2004-04-07 IL IL161308A patent/IL161308A/en active IP Right Grant
- 2004-04-13 ZA ZA2004/02806A patent/ZA200402806B/en unknown
- 2004-04-15 NO NO20041531A patent/NO325780B1/no not_active IP Right Cessation
-
2006
- 2006-05-03 US US11/416,321 patent/US7468443B2/en not_active Expired - Lifetime
-
2007
- 2007-07-09 CY CY20071100909T patent/CY1106714T1/el unknown
-
2008
- 2008-10-17 US US12/253,379 patent/US8129535B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL369601A1 (pl) | Pochodne eteru alkilowego lub ich sole | |
| NZ336560A (en) | 10,11-dihydro-3-[substituted pyridyl-1-alkoxy]-5H-dibenzo[a,d]cycloheptene-10-acetic acid derivatives useful as vitronectin receptor antagonists | |
| BG106451A (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
| HUT66971A (en) | 4-amino-naphthyridine derivatives pharmaceutical compositions containing the same and process for the production of thereof | |
| DK0508699T3 (da) | 9-deoxo-8a-aza-8a-homoerythromycin-A-derivater modificeret ved 4"- og 8a-stillingerne | |
| MY133473A (en) | Haterocyclic glycyl beta-alanine derivatives. | |
| ATE312105T1 (de) | Camptothecinanaloge, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen | |
| BR9910467A (pt) | Composto derivado de amida, processo para a preparação do mesmo, composição farmacêutica, e, uso de um composto derivado de amida | |
| WO2002044192A1 (en) | Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
| GEP20094723B (en) | Tetraazabenzo [e] azulene derivatives and analogs thereof | |
| WO2001096334A3 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
| TNSN05165A1 (fr) | Derives de pyrrolopyrimidine | |
| IL150565A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| MXPA02010405A (es) | Derivados de aminocarboxialquilo novedosos de acido barbiturico. | |
| FI963885A0 (fi) | Pyrimidiini- tai triatsiinikarboksyylihappojohdannaiset käytettäväksi lääkaineina | |
| BR9905981A (pt) | Compostos isocromano e processos para a sua produção. | |
| DE60032016D1 (de) | Zyklische aminverbindungen als ccr5-rezeptor antagonisten | |
| HU9801950D0 (en) | 2-(arylphenyl)-amino-imidazoline derivatives | |
| WO2004091633A8 (en) | Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof | |
| AU4842297A (en) | New N-benzylpiperazine compounds, process for their preparation and the pharmaceutical compositions which contain them | |
| AU2408602A (en) | Indole derivatives and use thereof in medicines | |
| JP2001519328A (ja) | Ｈｃｍｖ感染症治療のためのアゼチジノン誘導体 | |
| BR9611572A (pt) | Produção de um sal de ácido clavulânico | |
| AU2003236180A1 (en) | Hydroxymorpholinone derivative and medicinal use thereof | |
| BR9810031A (pt) | Derivados de ácido pirrolidina carboxìlico como antagonistas á endotelina |